These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21664687)

  • 21. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technology transfer in human vaccinology: a retrospective review on public sector contributions in a privatizing science field.
    Hendriks J
    Vaccine; 2012 Sep; 30(44):6230-40. PubMed ID: 22902679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and implementation of papillomavirus prophylactic vaccines.
    Frazer IH
    J Immunol; 2014 May; 192(9):4007-11. PubMed ID: 24748633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge.
    Iurescia S; Fioretti D; Fazio VM; Rinaldi M
    Biotechnol Adv; 2012; 30(1):372-83. PubMed ID: 21745560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A public-professional web-bridge for vaccines and vaccination: user concerns about vaccine safety.
    García-Basteiro AL; Alvarez-Pasquín MJ; Mena G; Llupià A; Aldea M; Sequera VG; Sanz S; Tuells J; Navarro-Alonso JA; de Arísteguí J; Bayas JM
    Vaccine; 2012 May; 30(25):3798-805. PubMed ID: 22027485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meeting the need for advocacy, social mobilisation and communication in the introduction of three new vaccines in South Africa - successes and challenges.
    Baleta AF; van den Heever J; Burnett RJ
    Vaccine; 2012 Sep; 30 Suppl 3():C66-71. PubMed ID: 22939025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of animal models in the development of human vaccines.
    Gerdts V; Littel-van den Hurk Sv; Griebel PJ; Babiuk LA
    Future Microbiol; 2007 Dec; 2(6):667-75. PubMed ID: 18041907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of reverse vaccinology in Schistosoma vaccine development: advances and prospects].
    Feng XG; Sui CY; Yuan CX; Shao DH; Chen JX; Lin JJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):237-47. PubMed ID: 18038788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
    Seib KL; Zhao X; Rappuoli R
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New technologies for vaccines.
    Dorner F; Eibl J; Barrett PN
    Wien Klin Wochenschr; 1999 Mar; 111(5):199-206. PubMed ID: 10226350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New pertussis vaccination approaches: en route to protect newborns?
    Locht C; Mielcarek N
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The next decade of vaccines: societal and scientific challenges.
    Moxon ER; Siegrist CA
    Lancet; 2011 Jul; 378(9788):348-59. PubMed ID: 21664685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of combined vaccines: manufacturers' viewpoint.
    André FE
    Biologicals; 1994 Dec; 22(4):317-21. PubMed ID: 7779355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preventing papillomavirus infectious and herpes zoster: new vaccines].
    Silbermann B; Launay O
    Med Sci (Paris); 2007 Apr; 23(4):423-7. PubMed ID: 17433234
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.